Results 1 to 5 of 5
IGXT (MC $32 M) 2 FDA Approvals coming + 2 new NDA filings in 4Q =10+ Bagger Gem
Undiscovered Intelgenx (IGXT) is definitely one of the most attractive and undervalued stock in the Biotech Sector . The Company has already 2 Drugs approved and another 2 Big Drugs close to FDA approval .BIG Partnership News could come any day for up to 3 Drugs for which IGXT got a Therm Sheet from a Global Pharma Company and there is another partnering discussion ongoing for 2 Drugs (see pipeline chart below) .
IGXT has a ridiculous Market Cap of less than $32 Million which is a Big Joke for a Company with such a MEGA Product Pipeline , this Co has everything to be the next 10 Bagger minimum .GL
Intelgenx (IGXT)
Market Cap: $31.8 Million
Cash: $2.1 Million
Price: $0.49
Burn-Rate: $400k per Quarter
Shares Out : 63.6 Million
•Announced a development and commercialization term sheet with a global pharmaceutical company for up to three products. If entered into, IntelGenx expects the definitive agreement to be finalized in the second quarter of 2016
Product :Rizaport (Migraine)
•European Mktg Approval–November 2015
•Planned USA submission to FDA Q4/2016
•Expected USA launch Q2/2017
Product :Tadalafil (Erectile Dysfunction) a better Oral thin-film version of Blockbuster Drug Cialis
•505(b)(2) USA NDA submission in Q4/2016
•Expected USA launch Q4/2017
Product :Indicated for Opioid Dependence
•Awaiting FDA approval
•According to IMS data, the oral film market for opioid dependence was worth more than $1.4B US in 2014.
Real-Time Best Bid & Ask
http://www.otcmarkets.com/stock/IGXT/quote
Strong Insider & Institutional Ownership on this Goldmine . Big Jump to new highs could come anytime now .GL
Insider Ownership :
Horst G. Zerbe 4,670,243.5 7.34%
Ingrid Zerbe 5,471,356.5 8.60%
Bernard J. Boudreau 287,500
Bernd Melcher 232,500
Andre Godin 214,500
Ian Troup 187,500
John Marinucc 175,000
Nadine Paiement 135,000
Clemens Mayr 68,750
John Durham 50,000
Robert Bechard 10,000
